Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2026-01-15 @ 3:13 PM
Study NCT ID:
NCT04415320
Status:
UNKNOWN
Last Update Posted:
2020-06-04
First Post:
2020-05-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
X-396 (Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases
Sponsor:
Betta Pharmaceuticals Co., Ltd.
Organization: